Successful treatment with sorafenib for sunitinib‐refractory metastatic papillary renal cell carcinoma: Potential impact of Raf overexpression on predicting the efficacy of sorafenib

INTRODUCTION: The prognosis of type 2 papillary renal cell carcinoma is often poor. We herein report a case of papillary renal cell carcinoma with liver metastasis that was successfully treated with sorafenib as a second‐line therapy. CASE PRESENTATION: An 82‐year‐old man who had undergone radical n...

Descripción completa

Detalles Bibliográficos
Autores principales: Morinaga, Ryota, Kawahara, Takashi, Teranishi, Jun‐ichi, Chuma, Makoto, Izumi, Koji, Miyoshi, Yasuhide, Yao, Masahiro, Otani, Masako, Miyamoto, Hiroshi, Uemura, Hiroji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292102/
https://www.ncbi.nlm.nih.gov/pubmed/32743370
http://dx.doi.org/10.1002/iju5.12035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292102/
https://www.ncbi.nlm.nih.gov/pubmed/32743370
http://dx.doi.org/10.1002/iju5.12035

Ejemplares similares